Monday: The beginning of the week was good for the markets: all benchmarks ended the trading session in the green. Moderna’s successful vaccine trial moved the markets. The most significant gains were by TECH100 and Germany30, which rose 3.85%, and 5.67%, respectively.
The short-selling ban for a handful of European countries ended.
Bank of Spain announced that the pandemic pushed the economy to set negative records. In just three months, the economy shrunk by 5.2%. The contraction is expected to increase by up to 12.4%.
Baidu had a better than expected Q1 report, as the pandemic forced people to stay indoors. In after-hours trading, the stock price went up 8%.
France and Germany have put together a monetary measure worth $545 billion debt-backed plan to help the most affected European countries get back on their feet.
Tuesday: Information about Moderna’s vaccine has surfaced and made the investors lose their trust. Benchmarks fell by 0.5% up to 1.59%.
Gold added 0.44% to $1, 753.20 per ounce.
Walmart had a better than expected financial report. Due to the pandemic, online sales grew by 74%. In after-hours trading, it gained more than 3%.
Kohl’s Q1 report was disappointing. Unlike Walmart, it lost 43% in just three months. This year alone, the stock price fell by 63%.
Wednesday: Europe started to ease the lockdown measures, which made the benchmarks gain.
Japan225 lost 0.05% after the country’s exports collapsed during the pandemic.
Gold lost what it gained on Tuesday, dropping by 0.49%.
Target had a good Q1, part of the pandemic, due to which the online services increased by 278%.
Thursday: The American benchmarks ended the day in red, with losses between 0.41% and 0.97%.
HongKong45 closed at 3.7% - reaching a seven-week low.
Ford had some problems when reopening some of the essential plants in the States. Some workers were found positive of infection. Until now, the stock fell 41%.
The unemployment report showed another 2.438 million jobless people. Since the lockdown, more than 38 million people are on unemployment benefits.
Friday: Japan225 gained 1.75 after the government announced a new potential stimulus package.
AstraZeneca announced sponsorship from the U.S. in its efforts to produce a viable vaccine against the virus. It has received $1 billion to push the gas-pedal in the developing process.
Alibaba posted their Q1 report, which exceeded analysts’ expectations. The revenue grew by 22% compared to the same time last year.
Stay updated with the latest market news! Register now!
Sources: investing.com, edition.cnn.com, marketwatch.com, cnbc.com, seekingalpha.com